-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MlL6ePamwsAYDe1E1RrPr+geNC378n+DYUuxlx0GMa6LtdpcciujzbdgaHrvriQb sidV/VwZ/3IKRUiClcVCBA== 0001179110-10-010247.txt : 20100610 0001179110-10-010247.hdr.sgml : 20100610 20100610163355 ACCESSION NUMBER: 0001179110-10-010247 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100608 FILED AS OF DATE: 20100610 DATE AS OF CHANGE: 20100610 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 45 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-274-8200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kovner Bruce CENTRAL INDEX KEY: 0001325713 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 10890685 MAIL ADDRESS: STREET 1: C/O CAXTON ASSOCIATES STREET 2: 500 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 edgar.xml FORM 4 - X0303 4 2010-06-08 0 0001157601 SYNTA PHARMACEUTICALS CORP SNTA 0001325713 Kovner Bruce C/O CAXTON ASSOCIATES LP 500 PARK AVENUE NEW YORK NY 10022 1 0 1 0 Common Stock 2010-06-08 4 P 0 26760 2.796 A 1527433 D Common Stock 2010-06-09 4 P 0 88532 2.925 A 1615965 D Common Stock 7761716 I By CxSynta LLC The shares were purchased in multiple transactions at prices ranging from $2.75 to $2.84 per share. The price reported above is the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The shares were purchased in multiple transactions at prices ranging from $2.86 to $2.96 per share. The price reported above is the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. These shares are owned directly by CxSynta LLC and indirectly by the Reporting Person as Chairman of Caxton Corporation, the managing member of CxSynta LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. /s/ Scott B. Bernstein, Attorney-in-Fact 2010-06-10 -----END PRIVACY-ENHANCED MESSAGE-----